Back to Search Start Over

Proteomic Analysis of Human Immune Responses to Live-Attenuated Tularemia Vaccine

Authors :
Duc M. Duong
Yie-Hwa Chang
Nicholas T. Seyfried
Nadine Rouphael
Mark J. Mulligan
Travis L. Jensen
Luming Yin
Patrick Sanz
Daniel F. Hoft
Johannes B. Goll
Casey E. Gelber
David C. Wood
Evan J. Anderson
Muktha S Natrajan
Robert A Johnson
Source :
Vaccines, Volume 8, Issue 3, Vaccines, Vol 8, Iss 413, p 413 (2020)
Publication Year :
2020
Publisher :
Multidisciplinary Digital Publishing Institute, 2020.

Abstract

Francisella tularensis (F. tularensis) is an intracellular pathogen that causes a potentially debilitating febrile illness known as tularemia. F. tularensis can be spread by aerosol transmission and cause fatal pneumonic tularemia. If untreated, mortality rates can be as high as 30%. To study the host responses to a live-attenuated tularemia vaccine, peripheral blood mononuclear cell (PBMC) samples were assayed from 10 subjects collected pre- and post-vaccination, using both the 2D-DIGE/MALDI-MS/MS and LC-MS/MS approaches. Protein expression related to antigen processing and presentation, inflammation (PPAR&gamma<br />nuclear receptor), phagocytosis, and gram-negative bacterial infection was enriched at Day 7 and/or Day 14. Protein candidates that could be used to predict human immune responses were identified by evaluating the correlation between proteome changes and humoral and cellular immune responses. Consistent with the proteomics data, parallel transcriptomics data showed that MHC class I and class II-related signals important for protein processing and antigen presentation were up-regulated, further confirming the proteomic results. These findings provide new biological insights that can be built upon in future clinical studies, using live attenuated strains as immunogens, including their potential use as surrogates of protection.

Details

Language :
English
ISSN :
2076393X
Database :
OpenAIRE
Journal :
Vaccines
Accession number :
edsair.doi.dedup.....e2e23f1e002ae216476ab338c60cd2fd
Full Text :
https://doi.org/10.3390/vaccines8030413